CervoMed awards Mark De Rosch 19,100 stock options

The options vest monthly over 36 installments and have a $2.24-per-share exercise price.

Rhea-AI Filing Summary

CervoMed Inc. reported that Mark De Rosch, EVP, RA and GA and PgM, received an award of 19,100 stock options on October 22, 2026, covering 19,100 shares of common stock. The options have an exercise price of $2.24 per share and vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month, beginning October 31, 2026. They expire October 22, 2036.

Insider Trade Summary

Grant/Award: 19,100 shares

Grant/Award 1 txn

Insider De Rosch Mark

Role EVP, RA and GA and PgM

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy) F1	19,100	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 19,100 contracts (Direct)

Footnotes (1)

1. F1. The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing October 31, 2026.

Key Figures

Stock options awarded: 19,100 options Exercise price: $2.24 per share Vesting schedule: 36 monthly installments +1 more

4 metrics

Stock options awarded 19,100 options Award reported October 22, 2026

Exercise price $2.24 per share Stock options covering common stock

Vesting schedule 36 monthly installments Equal (or as near equal as possible), beginning October 31, 2026

Expiration date October 22, 2036 Stock options

Key Terms

Stock Option (Right to Buy), exercise price, vest

3 terms

Stock Option (Right to Buy) financial

"the award of 19,100 stock options"

exercise price financial

"the options have an exercise price of $2.24 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vest financial

"the award will vest in monthly installments"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CRVO stock options did Mark De Rosch receive?

Mark De Rosch received an award of 19,100 stock options on October 22, 2026, covering 19,100 shares of CervoMed common stock.

When do Mark De Rosch’s CRVO options vest and expire?

The options vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month, beginning October 31, 2026. They expire October 22, 2036.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/23/2026 - 05:01 PM EDT Accepted by SEC EDGAR 10/23/2026 - 05:01 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

De Rosch Mark

(Last) (First) (Middle)

20 PARK PLAZA,

SUITE 424

(Street)

BOSTON MASSACHUSETTS 02116

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CervoMed Inc. [ CRVO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, RA and GA and PgM

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$2.24	10/22/2026		A		19,100		(1)	10/22/2036	Common Stock	19,100	$0	19,100	D

Explanation of Responses:

1. The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing October 31, 2026.

	/s/ William R. Elder, attorney-in-fact for the Reporting Person	10/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)